Author:
Danaei Mina,Bahadorizadeh Leyla,Dehnad Afsaneh,Mohamadzadeh Shirin,Hashemi-Madani Nahid,Khamseh Mohammad E.
Abstract
Abstract
Background
Acromegaly is a chronic disease significantly affects the physical, emotional, and health-related aspects of patients' life. This study aimed to validate the Acromegaly Quality of Life Questionnaire (AcroQoL) for the Persian-speaking population.
Methods
This cross-sectional study recruited 73 Iranian patients with a confirmed diagnosis of acromegaly. The content validity of the scales was evaluated by an expert panel of eight endocrinologists applying content validity index (CVI) and content validity ratio (CVR). Construct validity was assessed by using confirmatory factor analysis. Internal consistency was assessed on the basis of Cronbach’s alpha, and a goodness-of-fit (GoF) index was calculated to display whether the model fitted the data.
Results
CVI and CVR yielded values of 0.85 and 0.80, respectively (Acceptable CVI: > 0.78 and CVR: > 0.75). The average variances extracted (AVE) from physical and psychological dimensions were 0.520 and 0.462, respectively, exceeding the minimum criterion of 0.40. Cronbach’s alpha for physical and psychological dimensions equaled 0.868 and 0.866, respectively, indicating the adequate internal consistency of multiple items for each construct. The subscales’ R square and path coefficient were greater than the recommended threshold as 0.75 (physical dimension: 0.778, psychological dimension: 0.873), demonstrating the suitability of this criterion. Finally, the GoF value of 0.29 indicated the model's moderate fit.
Conclusions
The findings revealed that the Persian version of AcroQoL is of adequate validity and reliability for evaluating the quality of life of Iranian people with acromegaly.
Publisher
Springer Science and Business Media LLC
Subject
General Psychology,General Medicine
Reference33 articles.
1. Szcześniak DM, Jawiarczyk-Przybyłowska A, Matusiak Ł, Bolanowska A, Maciaszek J, Siemińska M, et al. Is there any difference in acromegaly and other chronic disease in quality of life and psychiatric morbidity? Endokrynol Pol. 2017;68(5):524–32.
2. Webb SM, Badia X. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur J Endocrinol. 2006;155(2):269–77.
3. Giustina A, Chanson P, Bronstein M, Klibanski A, Lamberts S, Casanueva F, et al. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab. 2010;95(7):3141–8.
4. Davi MV, Dalle Carbonare L, Giustina A, Ferrari M, Frigo A, Cascio VL, et al. Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur J Endocrinol. 2008;159(5):533–40.
5. Rokkas T, Pistiolas D, Sechopoulos P, Margantinis G, Koukoulis G. Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. WJG. 2008;14(22):3484.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Growth Hormone Excess: Implications and Management;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-05